Samsung (KS:) Biologics to offer ADC services at new dedicated facility Extended collaboration reflects successful partnership…
Tag: ADC
IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for SHR-4849, a Novel Phase 1 DLL3 Topo-I-Payload ADC Targeting SCLC and NET Solid Tumors
Exclusive global license outside of Greater China for SHR-4849, a Phase 1 DLL3-targeting Topo-I-payload antibody drug…
Mersana Therapeutics: We’re About To Find Out If ADC Platform Is More Tolerable (MRSN)
This article was written by Follow I have my PhD in biochemistry and have worked for…
ADC Therapeutics: Continues To Make Strides With ZYNLONTA Targeting DLBCL (NYSE:ADCT)
This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector…